Improve International has raised funds
Improve International Limited has completed its recapitalization through a US$7.7 million revolving credit facility provided by Santander. In June 2020, Improve International, a carve-out from Benchmark Holdings Plc, was sold to RJD Partners. The deal was equity-underwritten by RJD at the time, with the intention to repay capital 12 months later.
Founded in 1998, Improve International is the UK’s largest private provider (and a global provider) of postgraduate training for all veterinary practice staff. Improve’s primary business is the delivery of veterinarian training, with courses focused on CPD and postgraduate qualifications. The group also has another arm, ISVPS, which provides independent accreditation and certification of Improve’s courses. The business has 84 employees and operates from offices in Swindon, UK, and Porto, Portugal.
Oaklins Cavendish’s debt advisory team, based in the UK, supported Improve International through a full debt raising process, inclusive of preparing a lender information pack, review of financial model, agreeing lender approach, engaging with the lending community, arranging management presentations, overlaying the covenant structure into the finalized model, review of terms sheets, negotiating the most appropriate terms, navigating Santander through their final credit approval committee and leading negotiations on legal documentation.
Chris Convey
CFO, Improve International Limited
Contáctese con el equipo de la transacción
Transacciones relacionadas
Den Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Conozca másXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Conozca másMicrofinanciera Fundeser has been sold to Grupo Financiero Atlántida
Incofin has successfully exited its investment in Microfinanciera Fundeser in Nicaragua through two of its funds: Rural Impulse Fund II (RIF II) and agRIF. It has sold 100% of its stake in Microfinanciera Fundeser to Grupo Financiero Atlántida through its subsidiary, Inversiones Tres Lagos.
Conozca más